tiprankstipranks
Cardiol Therapeutics Secures $13.5M in Public Offering
Company Announcements

Cardiol Therapeutics Secures $13.5M in Public Offering

Story Highlights

Cardiol Therapeutics (TSE:CRDL) has released an update.

Don't Miss our Black Friday Offers:

Cardiol Therapeutics, a clinical-stage company specializing in heart disease treatments, has completed a public offering, raising US$13.5 million through the sale of its Class A common shares. These funds are earmarked for the clinical development of CardiolRx, aimed at treating recurrent pericarditis, and other corporate expenses.

For further insights into TSE:CRDL stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskCardiol Therapeutics Reports Promising Phase II Results
TipRanks Auto-Generated NewsdeskCardiol Therapeutics Faces Rising Losses and Falling Assets
TheFlyCardiol Therapeutics added to PRISM Emerging Biotech Index
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App